首页> 外国专利> MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA

MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA

机译:色素性视网膜色素沉着症的治疗材料和方法

摘要

The present application provides materials and methods for treating a patient with autosomal dominant RP, both ex vivo and in vivo; materials and methods for editing a RHO gene in a human cell; and materials and methods for editing a P23H mutation in a RHO gene in a human cell. In addition, the present application provides one or more gRNAs or sgRNAs for editing a RHO gene; one or more gRNAs or sgRNAs for editing a P23H mutation in a RHO gene; and a therapeutic comprising at least one or more gRNAs or sgRNAs for editing a P23H mutation in a RHO gene. The present application provides a therapeutic for treating a patient with autosomal dominant RP. The present application provides a kit for treating a patient with autosomal dominant RP. In addition, the present application provides a self-inactivating CRISPR-Cas system.
机译:本申请提供了用于体外和体内治疗具有常染色体显性RP的患者的材料和方法。在人类细胞中编辑RHO基因的材料和方法;以及在人细胞中编辑RHO基因中P23H突变的材料和方法。另外,本申请提供了一种或多种用于编辑RHO基因的gRNA或sgRNA。用于编辑RHO基因中的P23H突变的一种或多种gRNA或sgRNA;包括至少一种或多种用于编辑RHO基因中的P23H突变的gRNA或sgRNA的治疗剂。本申请提供了用于治疗具有常染色体显性RP的患者的疗法。本申请提供了一种用于治疗具有常染色体显性RP的患者的试剂盒。另外,本申请提供了自灭活的CRISPR-Cas系统。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号